Content about Albert Einstein College of Medicine

03.22.10

Researchers at Albert Einstein College of Medicine of Yeshiva University have found two novel ways of killing the bacteria that cause tuberculosis (TB), a disease responsible for an estimated two million deaths each year. The findings, published in the March 21 online issue of Nature Chemical Biology, could lead to a potent TB therapy that would also prevent resistant TB strains from developing...

10.09.09

Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today. Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean of Einstein, and eight stem cell researchers discussed advances in medical therapies and treatments that Einstein scientists have been investigating since receiving more than $14 million in State funding for stem cell research.

04.09.09

Scientists at Albert Einstein College of Medicine of Yeshiva University have developed a simple, accurate, and highly sensitive test to detect and quantify ricin, an extremely potent toxin with potential use as a bioterrorism agent.

04.09.09

Scientists at Albert Einstein College of Medicine of Yeshiva University have developed a simple, accurate, and highly sensitive test to detect and quantify ricin, an extremely potent toxin with potential use as a bioterrorism agent.

04.09.09

Scientists at Albert Einstein College of Medicine of Yeshiva University have developed a simple, accurate, and highly sensitive test to detect and quantify ricin, an extremely potent toxin with potential use as a bioterrorism agent.

04.01.09

Scientists at Albert Einstein College of Medicine of Yeshiva University have proposed a sweeping new theory of autism that suggests that the brains of people with autism are structurally normal but dysregulated, meaning symptoms of the disorder might be reversible.